Concurrent Investment Advisors LLC Raises Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Concurrent Investment Advisors LLC grew its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 98.7% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 9,873 shares of the medical equipment provider’s stock after buying an additional 4,905 shares during the quarter. Concurrent Investment Advisors LLC’s holdings in Intuitive Surgical were worth $4,850,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of the stock. International Assets Investment Management LLC increased its holdings in Intuitive Surgical by 49,383.6% in the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock valued at $535,788,000 after buying an additional 1,088,415 shares in the last quarter. Capital Research Global Investors acquired a new position in shares of Intuitive Surgical during the 1st quarter worth approximately $374,390,000. Vanguard Group Inc. lifted its position in shares of Intuitive Surgical by 1.6% during the 1st quarter. Vanguard Group Inc. now owns 30,868,620 shares of the medical equipment provider’s stock valued at $12,319,358,000 after buying an additional 493,126 shares in the last quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. lifted its holdings in Intuitive Surgical by 51.2% during the first quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 893,341 shares of the medical equipment provider’s stock valued at $356,524,000 after purchasing an additional 302,382 shares in the last quarter. Finally, Strategic Financial Concepts LLC grew its position in shares of Intuitive Surgical by 40,221.4% in the second quarter. Strategic Financial Concepts LLC now owns 266,121 shares of the medical equipment provider’s stock valued at $1,184,000 after purchasing an additional 265,461 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Robert Desantis sold 240 shares of the firm’s stock in a transaction that occurred on Monday, August 12th. The shares were sold at an average price of $464.76, for a total value of $111,542.40. Following the completion of the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,558,968.56. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. In other news, CEO Gary S. Guthart sold 18,151 shares of the firm’s stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the sale, the chief executive officer now directly owns 24,219 shares in the company, valued at approximately $12,391,166.97. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Robert Desantis sold 240 shares of the stock in a transaction on Monday, August 12th. The shares were sold at an average price of $464.76, for a total value of $111,542.40. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at $2,558,968.56. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 68,246 shares of company stock valued at $33,839,308 in the last ninety days. Company insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

ISRG has been the topic of a number of research reports. Royal Bank of Canada raised their price target on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. Citigroup raised their price objective on Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. Morgan Stanley upped their price objective on shares of Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a research note on Monday, July 15th. JPMorgan Chase & Co. raised their target price on shares of Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Finally, Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $513.74.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $515.55 on Thursday. The business has a 50-day moving average of $492.30 and a 200 day moving average of $450.05. Intuitive Surgical, Inc. has a 12 month low of $269.49 and a 12 month high of $525.00. The stock has a market capitalization of $183.63 billion, a price-to-earnings ratio of 82.89, a price-to-earnings-growth ratio of 4.99 and a beta of 1.39.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.